다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Kezar Life Sciences Inc (KZR)
Kezar Life Sciences Inc (KZR) 뉴스

KZR

Kezar Life Sciences (KZR)

Kezar Life Sciences Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:KZR

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/03/07	07:46	Edgar (US Regulatory)	Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:KZR	Kezar Life Sciences Inc
2025/03/06	10:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KZR	Kezar Life Sciences Inc
2025/03/04	06:01	Edgar (US Regulatory)	Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	NASDAQ:KZR	Kezar Life Sciences Inc
2025/02/28	06:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KZR	Kezar Life Sciences Inc
2025/02/19	06:01	Business Wire	Kezar Life Sciences to Present at Virtual KOL Event Hosted by William Blair on Zetomipzomib Clinical Development in Autoimmune Hepatitis and Provide a Safety Update from the PALIZADE Trial for Lupus Nephritis on February 27, 2025	NASDAQ:KZR	Kezar Life Sciences Inc
2025/02/15	08:53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KZR	Kezar Life Sciences Inc
2025/02/15	00:42	Edgar (US Regulatory)	Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:KZR	Kezar Life Sciences Inc
2025/02/11	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:KZR	Kezar Life Sciences Inc
2025/02/06	07:19	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:KZR	Kezar Life Sciences Inc
2025/01/14	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KZR	Kezar Life Sciences Inc
2025/01/14	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KZR	Kezar Life Sciences Inc
2025/01/10	23:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KZR	Kezar Life Sciences Inc
2024/12/04	06:45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KZR	Kezar Life Sciences Inc
2024/11/13	06:18	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:KZR	Kezar Life Sciences Inc
2024/11/13	06:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KZR	Kezar Life Sciences Inc
2024/11/13	06:01	Business Wire	Kezar Life Sciences Reports Third Quarter 2024 Financial Results and Provides Business Update	NASDAQ:KZR	Kezar Life Sciences Inc
2024/10/30	06:05	Edgar (US Regulatory)	Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend]	NASDAQ:KZR	Kezar Life Sciences Inc
2024/10/29	05:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KZR	Kezar Life Sciences Inc
2024/10/28	21:30	Business Wire	Kezar Life Sciences Announces 1-for-10 Reverse Stock Split	NASDAQ:KZR	Kezar Life Sciences Inc
2024/10/17	22:22	Edgar (US Regulatory)	Form 8-A12B - Registration of securities [Section 12(b)]	NASDAQ:KZR	Kezar Life Sciences Inc
2024/10/17	21:47	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KZR	Kezar Life Sciences Inc
2024/10/17	21:35	Business Wire	Kezar Board Unanimously Rejects Unsolicited Concentra Proposal and Adopts Limited Duration Stockholder Rights Plan	NASDAQ:KZR	Kezar Life Sciences Inc
2024/10/17	21:30	Business Wire	Kezar Life Sciences Announces Positive IDMC Safety Review of PORTOLA Trial of Zetomipzomib in Patients with Autoimmune Hepatitis and Provides PALIZADE Update	NASDAQ:KZR	Kezar Life Sciences Inc
2024/10/10	21:42	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KZR	Kezar Life Sciences Inc
2024/10/10	21:30	Business Wire	Kezar Confirms Receipt of Unsolicited, Non-Binding Acquisition Proposal	NASDAQ:KZR	Kezar Life Sciences Inc
2024/10/05	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KZR	Kezar Life Sciences Inc
2024/10/05	06:00	Business Wire	Kezar Life Sciences Announces Clinical Hold of Zetomipzomib IND for Treatment of Lupus Nephritis	NASDAQ:KZR	Kezar Life Sciences Inc
2024/09/30	21:36	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KZR	Kezar Life Sciences Inc
2024/09/30	21:30	Business Wire	Kezar Life Sciences Announces Cessation of Enrollment and Dosing in the Phase 2b PALIZADE Trial of Zetomipzomib in Active Lupus Nephritis Patients	NASDAQ:KZR	Kezar Life Sciences Inc
2024/09/05	05:01	Business Wire	Kezar Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference	NASDAQ:KZR	Kezar Life Sciences Inc

검색 관련기사 보기:NASDAQ:KZR

1 2 3 4 5 6 7 8 9 10 다음 >>

Invesco QQQ Trust Series 1

BNP Paribas (QX)

Deutsche Telekom (QX)

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관